Pfizer, Allergan Confirm Preliminary Merger Talks Print E-mail
By FDAnews Drug Daily Bulletin   
Thursday, 05 November 2015 11:37

Pfizer is in preliminary talks to purchase part or all of Irish drugmaker Allergan, the two companies confirmed last week.

News of the talks comes seven months after Allergan — which is best known as the maker of Botox (botulinum toxin) — was purchased by Actavis in a deal valued at roughly $70 billion. Actavis subsequently changed its name to Allergan.

 

NEWS FROM FDA WEBSITE




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter